| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-07 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.19 | 8e-07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.16 | 8e-07 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-06 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.17 | 3e-06 |